Aripiprazole versus Bupropion Augmentation in Patients with Anxious Depression Resistant to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-label, Multicenter Study
Clinical Psychopharmacology and Neuroscience · 30.11.2026 · 24 (4) · 832-843
DOI: 10.9758/cpn.26.1422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Psychopharmacology and Neuroscience, online erschienen am 08.07.2026. Verfasst von So-Hye Jo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, College of Medicine, Yeungnam University, Daegu, Korea. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Otsuka Pharmaceutical Co., Ltd., Korea.
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, College of Medicine, Yeungnam University, Daegu, Korea.
- Lee Gwang-hun Psychiatry Clinic, Gyeongju, Korea.
- Department of Psychiatry, College of Medicine, Daegu Catholic University, Daegu, Korea.
- Department of Psychiatry, Kyungpook National University School of Medicine, Daegu, Korea.
- Park Young-woo Psychiatric Clinic, Daegu, Korea.
- Department of Psychiatry, Soonchunhyang University Gumi Hospital, Gumi, Korea.
ORCID-Profile: So-Hye Jo, Bon-Hoon Koo, Kwang-Hun Lee, Jong-Hun Lee, Seung-Jae Lee, Young-Woo Park, Hyung-Mo Sung, Eun-Jin Cheon
Förderung
- Otsuka Pharmaceutical Co., Ltd., Korea
Zitieren
APA
Jo, S. H., Koo, B. H., Lee, K. H., Lee, J. H., Lee, S. J., Park, Y. W., Sung, H. M., & Cheon, E. J. (2026). Aripiprazole versus Bupropion Augmentation in Patients with Anxious Depression Resistant to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-label, Multicenter Study. Clinical Psychopharmacology and Neuroscience, 24(4), 832-843. https://doi.org/10.9758/cpn.26.1422
Vancouver
Jo SH, Koo BH, Lee KH, Lee JH, Lee SJ, Park YW, et al. Aripiprazole versus Bupropion Augmentation in Patients with Anxious Depression Resistant to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-label, Multicenter Study. Clinical Psychopharmacology and Neuroscience. 2026;24(4):832-843. doi:10.9758/cpn.26.1422
BibTeX
@article{Jo2026,
author = {Jo, So-Hye and Koo, Bon-Hoon and Lee, Kwang-Hun and Lee, Jong-Hun and Lee, Seung-Jae and Park, Young-Woo and Sung, Hyung-Mo and Cheon, Eun-Jin},
title = {Aripiprazole versus Bupropion Augmentation in Patients with Anxious Depression Resistant to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-label, Multicenter Study},
journal = {Clinical Psychopharmacology and Neuroscience},
year = {2026},
volume = {24},
number = {4},
pages = {832--843},
doi = {10.9758/cpn.26.1422}
}
EUVIMED